ФАКТОРЫ, ВЛИЯЮЩИЕ НА ИСХОДЫ ХРОНИЧЕСКОЙ ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТИ ПРИ ГЕМОДИАЛИЗЕ
Актуальность. Высокая смертность у диализных пациентов (в 6,3-8,2 раза выше, чем в общей популяции) мотивирует на поиск и выявление потенциальных факторов риска, чтобы улучшить выживаемость.
Цель. Данный обзор посвящен анализу литературных источников по выявлению факторов, влияющих на исходы у пациентов с хронической почечной недостаточностью, находящихся на гемодиализе.
Стратегия поиска. Проведен поиск научных публикаций в поисковых системах Pub Med, Google Scholar, Google Academia, в электронной научной библиотеке eLibrary.ru, CyberLeninka глубиной 10 лет. Критерии включения: глубина поиска составила 10 лет (2009-2019); публикации на казахском, русском и английском языках; полнотекстовые эпидемиологические и клинические исследования. Критерии исключения: публикации с исследованиями, проведенными на животных, повторно встречающиеся публикации, материалы конференций и клинические случаи.
Результаты. В качестве основных предикторов смертности и выживаемости пациентов, находящихся на гемодиализе, по данным литературы, изучались доза и частота проведения диализа, остаточная функция почек.
Выводы. Анализ литературных данных показал, что наиболее значимым фактором, определяющим исходы хронической почечной недостаточности при гемодиализе, является остаточная функция почек.
Сауле Б. Бодесова 1, http://orcid.org/0000-0002-3697-8823
Багдат Г. Султанова 1,
Назира Б. Бекенова 2, http://orcid.org/0000-0002-3312-3299
1 АО «Казахский медицинский университет непрерывного образования»,
г. Алматы, Республика Казахстан;
2 НАО «Государственный медицинский университет»,
г. Семей, Республика Казахстан.
1. Абрамова Е.Е., Королева И.Е., Тов Н.Л., Мовчан Е.А., Наборщиков Д.А. Факторы риска летальныx исxодов у больныx на гемодиализе // Сибирский медицинский журнал. 2015. No.6. С.1-12.
2. Кичигин В. А., Козлов Д.О., Киx О.В., Волкова Т.А. Выживаемость пациентов, получающих программный гемодиализ (обзор) // Acta Medica Eurasica. 2018. No 1. С. 22-35.
3. Kobalava Zh. D., Villeval`de S. V., Efremovceva M. A. Хроническая болезнь почек: определение, классификация, принципы диагностики и лечения // Российский кардиологический журнал. 2013. No 4 (102). C.95-103.
4. Коломиец В.И., Нишкумай О.И., Одуд О.И., Гринев М.А. Эффективность альфакальцидола у пациентов с хронической болезнью почек на гемодиализе // Украинский журнал клинической лабораторной медицины. 2013. No 8. С. 37-40.
5. Марченко Д.Н., Клигуненко Е.Н., Площенко Ю.А., Сединкин В.А., Москвинова Н.А. Программный гемодиализ у пациента с поликистозом почек и аллопротезированием митрального и трикуспидального клапанов в периоперационном периоде: клинический случай // Неотложная медицинская помощь. 2017. No 5 (84). С.121-124.
6. Пилотович В.С., Калачик О.В. Хроническая болезнь почек. Методы заместительной почечной терапии // Медицинская литература. 2009. С. 91-94.
7. Ртищева О.В., Калев О.Ф., Аксматов В.Ю. Структура причин смерти у больных на программном гемодиализе // Клиническая неврология. 2011. No 1. С. 43-45.
8. Смирнов А.В., Седов В.М., Лхаксуу Од-Эрдене, Каюков И.Г., Добронравов В.А., Панина И.Ю. Снижение скорости клубочковой фильтрации как независимого фактора риска сердечно-сосудистых заболеваний // Неврология. 2006. No. 4 (10). С.7-17.
9. Стезюк Е.А. Основы гемодиализа // Москва: Геотар-Мед, 2001. 200p.
10. Шарипова X.Й., Гулов М.К., Исмаилов С.С., Тагоев С.Х., Соксибов Р.Г. Терминальная хроническая почечная недостаточность: оценка риска, этапы терапии и проблемы с сердцем // Бюллетень Авиценны. 2013. No2. PP. 153-159.
11. Araujo S.Р., Lemes H.P., Cunha D.A., Queiroz V.S., Nascimento D.D., Ferreira Filho S.R. Cardiac morphology and function in patients with and without residual diuresis on hemodialysis // Brazilian Journal of Nephrology. 2011. N 33(1). P. 74-81.
12. Balík M., Jabor A., Kolář M., Pavlisová M., Břešt’an D., Hendl J., Pachl J. Relationship between natriuretic peptides and residual diuresis during continuous hemodiafiltration // Blood purification. 2003. N 21(6), P. 401-408.
13. Chandrashekar A., Ramakrishnan S., Rangarajan D. Survival analysis of patients on maintenance hemodialysis // Indian journal of nephrology. 2014. N 24(4). P. 206-213.
14. Chen, Y., Liu, H., Zou, J., Ge, Y., Teng, J., Xu, S, Shen, B. (2013). 24-h residual urine volume at hemodialysis initiation: A possible predictor for acute ischemic stroke incurrence in hemodialyis patients. // Clinical neurology and neurosurgery. 2013. N 115(5), 557-561.
15. Chung, S. H., Han, D. C., Noh, H., Jeon, J. S., Kwon, S. H., Lindholm, B., Lee, H. B. Risk factors for mortality in diabetic peritoneal dialysis patients //Nephrology Dialysis Transplantation. 2010. N 25 (11). P. 3742-3748.
16. Collins, A. J., Foley, R. N., Herzog, C., Chavers, B., Gilbertson, D., Herzog, C., Liu, J.. US Renal Data System 2012 annual data report // American Journal of Kidney Diseases. 2013. N 61(1), P. 451-459.
17. Depner, T., Daugirdas, J., Greene, T. , Allon, M., Beck, G., Chumlea, C., Macon, E. Dialysis dose and the effect of gender and body size on outcome in the HEMO Study // Kidney international. 2004. N 65(4), P. 1386-1394.
18. Eknoyan, G. A, Beck, G. J., Cheung, A. K., Daugirdas, J. T., Greene, T., Kusek, J. W., Dwyer, J. T. Effect of dialysis dose and membrane flux in maintenance hemodialysis // New England Journal of Medicine. 2002. N 347(25), P. 2010-2019.
19. Hwang, H. S., Hong, Y. A., Yoon, H. E., Chang, Y. K., Kim, S. Y., Kim, Y. O., Kang, S. W.. Comparison of clinical outcome between twice-weekly and thrice-weekly hemodialysis in patients with residual kidney function // Medicine. 2016. N 95(7). P. 1-8.
20. Kalantar-Zadeh, K., Unruh, M., Zager, P. G., Kovesdy, C. P., Bargman, J. M., Chen, J., Goldfarb, D. S. Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy // American Journal of Kidney Diseases. 2014. N 64(2). P. 181-186.
21. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease // Kidney Int. Supplement. 2013; 3:1–150.
22. Lee, M. J., Park, J. T., Park, K. S., Kwon, Y. E., Oh, H. J., Yoo, T. H., Kang, S. W.. Prognostic value of residual urine volume, GFR by 24-hour urine collection, and eGFR in patients receiving dialysis // Clinical Journal of the American Society of Nephrology. 2017. N 12(3). P. 426-434.
23. Lin X., Yan Y., Ni Z., Gu L., Zhu M., Dai H., Qian J. Clinical outcome of twice-weekly hemodialysis patients in shanghai // Blood purification. 2012. N 33(1-3). P. 66-72.
24. Lin Y. F., Huang J. W., Wu M. S., Chu T. S., Lin S. L., Chen Y. M., Wu K. D. Comparison of residual renal function in patients undergoing twice‐weekly versus three‐times‐weekly hemodialysis // Nephrology. 2009. N 14(1). P. 59-64.
25. Locatelli F., Pozzoni P., Tentori F., Del Vecchio L. Epidemiology of cardiovascular risk in patients with chronic kidney disease // Nephrology Dialysis Transplantation. 2003. N 18(7). P. 2-9.
26. Ma T., Ding G. Effects of residual renal function on left ventricle and analysis of related factors in patients with hemodialysis //Renal failure. 2013. N 35 (2). P. 198-203.
27. Mathew A. T., Fishbane S., Obi Y., Kalantar-Zadeh K. Preservation of residual kidney function in hemodialysis patients: reviving an old concept // Kidney international. 2016. 90(2). P. 262-271.
28. Moist L. M., Port F. K., Orzol S. M., Young E. W., Ostbye T., Wolfe R. A., Bloembergen W. E. Predictors of loss of residual renal function among new dialysis patients // Journal of the American Society of Nephrology. 2009. N 11(3). P. 556-564.
29. National Kidney Foundation. DOQI Clinical Practice Guidelines for Chronic Kidney Disease. Executive Summary. http://www.kidney.org/ guidelines. 2002.
30. Obi Y., Rhee C. M., Mathew A. T., Shah G., Streja E., Brunelli S. M, Kalantar-Zadeh K. Residual kidney function decline and mortality in incident hemodialysis patients // Journal of the American Society of Nephrology. 2016. 27(12). P. 3758-3768.
31. Perl J., Bargman J. M. The importance of residual kidney function for patients on dialysis: a critical review //American Journal of Kidney Diseases. 2009. N 53 (6). P. 1068-1081.
32. Pozzoni P., Del L. V., Pontoriero G., Di S. F., Locatelli F. Long-term outcome in hemodialysis: morbidity and mortality // Journal of nephrology. 2004. N 17. P. 87-95.
33. Rhee C. M., Unruh M., Chen J., Kovesdy C. P., Zager P., Kalantar‐Zadeh K. Infrequent dialysis: a new paradigm for hemodialysis initiation // In Seminars in dialysis., November 2013. P. 720-727.
34. Shafi T., Jaar B. G., Plantinga L. C., Fink N. E., Sadler J. H., Parekh R. S., Coresh J. Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study // American Journal of Kidney Diseases. 2010. N 56(2). P. 348-358.
35. Shemin D., Bostom A. G., Laliberty P., Dworkin L. D. Residual renal function and mortality risk in hemodialysis patients // American journal of kidney diseases. 2008. N 38(1). P. 85-90.
36. Suda T., Hiroshige K., Ohta T., Watanabe Y., Iwamoto M., Kanegae K., Nakashima Y. The contribution of residual renal function to overall nutritional status in chronic hemodialysis patients // Nephrology Dialysis Transplantation. 2009. N 15(3). P. 396-401.
37. Tamura M. K., Yaffe K. Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies //Kidney international. 2011. N 79 (1). P. 14-22.
38. Tang W., Li L. X., Pei J., Wang T. Heart rate variability in peritoneal dialysis patients: what is the role of residual renal function? // Blood purification. 2012. N 34(1). P. 58-66.
39. United States Renal Data System, United States Renal Data System. Excerpts from USRDS 2009 Annual Data Report. US Department of Health and Human Services. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases //Am J Kidney Dis. 2010. N 55. (Suppl 1).
40. Van Olden R. W., Van Acker B. A. C., Koomen G. C. M., Krediet R. T., Arisz L. Time course of inulin and creatinine clearance in the interval between two haemodialysis treatments. // Nephrology Dialysis Transplantation. 1995. N 10(12). P. 2274-2280.
41. Vanholder R. New insights in uremic toxins //Kidney International. 2003. N 63. P. 6-10.
42. Verdecchia, P., Carini, G., Circo, A., Dovellini, E., Giovannini, E., Lombardo, M., .MAVI Study Group. Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study // Journal of the American College of Cardiology. 2011. N 38(7). P. 1829-1835.
43. Vilar, E., Wellsted, D., Chandna, S. M., Greenwood, R. N., Farrington, K. Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose // Nephrology Dialysis Transplantation. 2009. N 24(8). P. 2502-2510.
44. Walser M. Dialysis and protein malnutrition // Kidney International. 2009. N 56 (1). P. 1139-1144.
45. Wang M., You L., Li H., Lin Y., Zhang Z., Hao C., Chen J. Association of circulating fibroblast growth factor-23 with renal phosphate excretion among hemodialysis patients with residual renal function // Clinical Journal of the American Society of Nephrology. 2013. N 8(1). P. 116-125.
46. Wright J. R., Ala’a E. S., Cooper A., Kalra P. R., Foley R. N., Kalra P. A. (2005). Left ventricular morphology and function in patients with atherosclerotic renovascular disease // Journal of the American Society of Nephrology. 2005. N 16(9). P. 2746-2753.
47. Zhang M., Wang M., Li H., Yu P., Yuan L., Hao C., Kalantar-Zadeh K. Association of initial twice-weekly hemodialysis treatment with preservation of residual kidney function in ESRD patients // American journal of nephrology. 2014. N 40(2). P. 140-150.
References
1. Abramova E. E`., Koroleva I.E., Tov N.L., Movchan E.A., Naborshhikov D.A. Faktory` riska letal`ny`x isxodov u bol`ny`x na gemodialize [Risk factors for lethal outcomes in patients on hemodialysis] //Journal of Siberian Medical Sciences. 2015. No. 6. PP.1-12. [in Russian]
2. Kichigin V. A., Kozlov D.O., Kix O.V., Volkova T. A. Vy`zhivaemost` pacientov, poluchayushhix programmny`j gemodializ (obzor) [Survival of patients receiving programmed hemodialysis (review)]. Acta Medica Eurasica. 2018. No 1. PP. 22-35. [in Russian]
3. Kobalava Zh. D., Villeval`de S. V., Efremovceva M. A. Xronicheskaya bolezn` pochek: opredelenie, klassifikaciya, principy` diagnostiki i lecheniya [Chronic kidney disease: definition, classification, principles of diagnosis and treatment]. Rossijskij kardiologicheskij zhurnal [Russian journal of cardiology]. 2013. No 4 (102).PP.95-103. [in Russian]
4. Kolomiecz V. I., Nishkumaj O.I., Odud O.I., Grinev M.A. E`ffektivnost` primeneniya al`fakal`cidola u pacientov s xronicheskoj bolezn`yu pochek, naxodyashhixsya na gemodialize [The effectiveness of alfacalcidol in patients with chronic kidney disease on hemodialysis]. Ukrainskij zhurnal klinicheskoj laboratornoj mediciny`.[Ukrainian Journal of Clinical Laboratory Medicine.] 2013. No 8. PP. 37-40. [in Russian]
5. Marchenko D. N., Kligunenko E.N., Ploshhenko Yu.A., Sedinkin V.A., Moskvinova N.A. Programmny`j gemodializ u pacienta s polikistozom pochek i alloprotezirovaniem mitral`nogo i trikuspidal`nogo klapanov v perioperacionnom periode: klinicheskij sluchaj [Programmed hemodialysis in a patient with polycystic kidney disease and alloprosthetics of mitral and tricuspid valves in the perioperative period: a clinical case]. .Medicina neotlozhny`x sostoyanij [Emergency Medicine.] 2017. No 5 (84). PP.121-124. [in Russian]
6. Pilotovich V. S., Kalachik O. V. Xronicheskaya bolezn` pochek. Metody` zamestitel`noj pochechnoj terapii [Chronic kidney disease. Renal replacement therapy methods] M.: Medicinskaya literatura. [Medicine literature]. 2009. PP. 91-94. [in Russian]
7. Rtishheva O. V., Kalev O. F., Axmatov V. Yu. Struktura prichin letal`ny`x isxodov u bol`ny`x, naxodyashhixsya na programmnom gemodialize [The structure of the causes of death in patients on programmed hemodialysis]. Клиническая нефрология [Clinical Nephrology] 2011. No 1. PP. 43-45. [in Russian]
8. Smirnov A. V., Sedov V.M., Lxaxuu Od-E`rdene, Kayukov I.G., Dobronravov V.A., Panina I.Yu. Snizhenie skorosti klubochkovoj fil`tracii kak nezavisimy`j faktor riska serdechno-sosudistoj bolezni [Decreased glomerular filtration rate as an independent risk factor for cardiovascular disease]. Нефрология [Nephrology] 2006. No. 4(10). PP.7-17. [in Russian]
9. Steczyuk E. A. Osnovy` gemodializa [Basics of hemodialysis.] Moskva: Ge`otar-Med, 2001.200p. [in Russian]
10. Sharipova X. Yo. , Gulov M.K., Ismailov S.S., Tagoev S.X., Soxibov R.G. Terminal`naya xronicheskaya pochechnaya nedostatochnost`: ocenka riska, e`tapy` terapii i kardial`ny`e problem [Terminal chronic renal failure: risk assessment, stages of therapy, and cardiac problems]. Vestnik Avicenny` [Avicenna Bulletin]. 2013. No 2. PP. 153-159. [in Russian]
11. Araujo S.Р., Lemes H. P., Cunha D. A., Queiroz V. S., Nascimento D. D., Ferreira Filho S. R. Cardiac morphology and function in patients with and without residual diuresis on hemodialysis. Brazilian Journal of Nephrology. 2011, 33(1), pp. 74-81.
48. Balík M., Jabor A., Kolář M., Pavlisová M., Břešt’an D., Hendl J., Pachl J. Relationship between natriuretic peptides and residual diuresis during continuous hemodiafiltration. Blood purification. 2003, 21(6), pp. 401-408.
49. Chandrashekar A., Ramakrishnan S., Rangarajan D. Survival analysis of patients on maintenance hemodialysis. Indian journal of nephrology. 2014, 24(4), pp. 206-213.
50. Chen Y., Liu H., Zou J., Ge Y., Teng J., Xu S, Shen B. 24-h residual urine volume at hemodialysis initiation: A possible predictor for acute ischemic stroke incurrence in hemodialyis patients. Clinical neurology and neurosurgery. 2013, 115(5), pp. 557-561.
51. Chung S. H., Han D. C., Noh H., Jeon J. S., Kwon S. H., Lindholm B., Lee H. B. Risk factors for mortality in diabetic peritoneal dialysis patients. Nephrology Dialysis Transplantation. 2010, 25 (11), pp. 3742-3748.
52. Collins A. J., Foley R. N., Herzog C., Chavers B., Gilbertson D., Herzog C., Liu J. US Renal Data System 2012 annual data report. American Journal of Kidney Diseases. 2013, 61(1), pp. 451-459.
53. Depner T., Daugirdas J., Greene T. , Allon M., Beck G., Chumlea C., Macon E. Dialysis dose and the effect of gender and body size on outcome in the HEMO Study. Kidney international. 2004, 65(4), pp. 1386-1394.
54. Eknoyan G. A, Beck G. J., Cheung A. K., Daugirdas J. T., Greene T., Kusek J. W., Dwyer J. T. Effect of dialysis dose and membrane flux in maintenance hemodialysis. New England Journal of Medicine. 2002, 347(25), pp. 2010-2019.
55. Hwang H. S., Hong Y. A., Yoon H. E., Chang Y. K., Kim S. Y., Kim Y. O., Kang S. W. Comparison of clinical outcome between twice-weekly and thrice-weekly hemodialysis in patients with residual kidney function. Medicine. 2016, 95(7), pp. 1-8.
56. Kalantar-Zadeh K., Unruh M., Zager P. G., Kovesdy C. P., Bargman J. M., Chen J., Goldfarb D. S. Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapyю American Journal of Kidney Diseases. 2014, 64(2), pp. 181-186.
57. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. Supplement. 2013, 3:1–150.
58. Lee M. J., Park J. T., Park K. S., Kwon Y. E., Oh H. J., Yoo T. H., Kang S. W. Prognostic value of residual urine volume, GFR by 24-hour urine collection, and eGFR in patients receiving dialysis. Clinical Journal of the American Society of Nephrology. 2017, 12(3), pp. 426-434.
59. Lin X., Yan Y., Ni Z., Gu L., Zhu M., Dai H., Qian J. Clinical outcome of twice-weekly hemodialysis patients in shanghai. Blood purification. 2012, 33(1-3), pp. 66-72.
60. Lin Y. F., Huang J. W., Wu M. S., Chu T. S., Lin S. L., Chen Y. M., Wu K. D. Comparison of residual renal function in patients undergoing twice‐weekly versus three‐times‐weekly hemodialysis. Nephrology. 2009, 14(1), pp. 59-64.
61. Locatelli F., Pozzoni P., Tentori F., Del Vecchio L. Epidemiology of cardiovascular risk in patients with chronic kidney disease. Nephrology Dialysis Transplantation. 2003, 18(7), pp. 2-9.
62. Ma T., Ding G. Effects of residual renal function on left ventricle and analysis of related factors in patients with hemodialysis. Renal failure. 2013, 35 (2), pp. 198-203.
63. Mathew A. T., Fishbane S., Obi Y., Kalantar-Zadeh K. Preservation of residual kidney function in hemodialysis patients: reviving an old concept. Kidney international. 2016, 90(2), pp. 262-271.
64. Moist L. M., Port F. K., Orzol S. M., Young E. W., Ostbye T., Wolfe R. A., Bloembergen W. E. Predictors of loss of residual renal function among new dialysis patients. Journal of the American Society of Nephrology. 2009, 11(3), pp. 556-564.
65. National Kidney Foundation. DOQI Clinical Practice Guidelines for Chronic Kidney Disease. Executive Summary. http://www.kidney.org/ guidelines. 2002.
66. Obi Y., Rhee C. M., Mathew A. T., Shah G., Streja E., Brunelli S. M, Kalantar-Zadeh K. Residual kidney function decline and mortality in incident hemodialysis patients. Journal of the American Society of Nephrology. 2016, 27(12), pp. 3758-3768.
67. Perl J., Bargman J. M. The importance of residual kidney function for patients on dialysis: a critical review. American Journal of Kidney Diseases. 2009, 53 (6), pp. 1068-1081.
68. Pozzoni P., Del L. V., Pontoriero G., Di S. F., Locatelli F. Long-term outcome in hemodialysis: morbidity and mortality. Journal of nephrology. 2004, 17, pp. 87-95.
69. Rhee C. M., Unruh M., Chen J., Kovesdy C. P., Zager P., Kalantar‐Zadeh K. Infrequent dialysis: a new paradigm for hemodialysis initiation. In Seminars in dialysis., November 2013, pp. 720-727.
70. Shafi T., Jaar B. G., Plantinga L. C., Fink N. E., Sadler J. H., Parekh R. S., Coresh J. Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. American Journal of Kidney Diseases. 2010, 56(2), pp. 348-358.
71. Shemin D., Bostom A. G., Laliberty P., Dworkin L. D. Residual renal function and mortality risk in hemodialysis patients. American journal of kidney diseases. 2008, 38(1), pp. 85-90.
72. Suda T., Hiroshige K., Ohta T., Watanabe Y., Iwamoto M., Kanegae K., Nakashima Y. The contribution of residual renal function to overall nutritional status in chronic hemodialysis patients. Nephrology Dialysis Transplantation. 2009, 15(3), pp. 396-401.
73. Tamura M. K., Yaffe K. Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies. Kidney international. 2011, 79 (1), pp. 14-22.
74. Tang W., Li L. X., Pei J., Wang T. Heart rate variability in peritoneal dialysis patients: what is the role of residual renal function? Blood purification. 2012, 34(1), pp. 58-66.
75. United States Renal Data System, United States Renal Data System. Excerpts from USRDS 2009 Annual Data Report. US Department of Health and Human Services. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases //Am J Kidney Diseases. 2010, 55. (Suppl 1).
76. Van Olden R. W., Van Acker B. A. C., Koomen G. C. M., Krediet R. T., Arisz L. Time course of inulin and creatinine clearance in the interval between two haemodialysis treatments. Nephrology Dialysis Transplantation. 1995, 10(12), pp. 2274-2280.
77. Vanholder R. New insights in uremic toxins. Kidney International. 2003, 63. pp. 6-10.
78. Verdecchia, P., Carini, G., Circo, A., Dovellini, E., Giovannini, E., Lombardo, M., .MAVI Study Group. Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study. Journal of the American College of Cardiology. 2011, 38(7), pp. 1829-1835.
79. Vilar, E., Wellsted, D., Chandna, S. M., Greenwood, R. N., Farrington, K. Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose. Nephrology Dialysis Transplantation. 2009, 24(8), pp. 2502-2510.
80. Walser M. Dialysis and protein malnutrition. Kidney International. 2009, 56 (1), pp. 1139-1144.
81. Wang M., You L., Li H., Lin Y., Zhang Z., Hao C., Chen J. Association of circulating fibroblast growth factor-23 with renal phosphate excretion among hemodialysis patients with residual renal function. Clinical Journal of the American Society of Nephrology. 2013, 8(1), pp. 116-125.
82. Wright J. R., Ala’a E. S., Cooper A., Kalra P. R., Foley R. N., Kalra P. A. Left ventricular morphology and function in patients with atherosclerotic renovascular disease. Journal of the American Society of Nephrology. 2005, 16(9), pp. 2746-2753.
83. Zhang M., Wang M., Li H., Yu P., Yuan L., Hao C., Kalantar-Zadeh K. Association of initial twice-weekly hemodialysis treatment with preservation of residual kidney function in ESRD patients. American journal of nephrology. 2014, 40(2), pp. 140-150.
Number of Views: 269
Category of articles:
Reviews
Bibliography link
Бодесова С.Б., Султанова Б.Г., Бекенова Н.Б. Факторы, влияющие на исходы хронической почечной недостаточности при гемодиализе // Наука и здравоохранение. 2019. 4 (Т.21). С. 28-36.Related publications:
INTERRELATION OF INTRAABDOMINAL HYPERTENSION AND MARKERS OF GASTROINTESTINAL TRACT INJURY IN PATIENTS WITH MULTIORGAN DYSFUNCTION
DRUG-INDUCED LIVER INJURY AND GENDER DIFFERENCES
QUALITY OF LIFE IN PRIMARY BILIARY CHOLANGITIS AND ITS ASSESSMENT
DIAGNOSTIC AND THERAPEUTIC LAPAROSCOPY FOR ABDOMINAL INJURIES. REVIEW
METHODS FOR SCHOOL-AGE CHILDREN NUTRITIONAL STATUS ASSESSMENT: FOCUS ON ANTHROPOMETRIC PARAMETERS. A REVIEW.